These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26301727)

  • 1. Total Synthesis of Prostaglandin 15d-PGJ(2) and Investigation of its Effect on the Secretion of IL-6 and IL-12.
    Egger J; Fischer S; Bretscher P; Freigang S; Kopf M; Carreira EM
    Org Lett; 2015 Sep; 17(17):4340-3. PubMed ID: 26301727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome.
    Shibata T; Yamada T; Kondo M; Tanahashi N; Tanaka K; Nakamura H; Masutani H; Yodoi J; Uchida K
    Biochemistry; 2003 Dec; 42(47):13960-8. PubMed ID: 14636064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
    Kim DH; Kim EH; Na HK; Surh YJ
    Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.
    Yu X; Egner PA; Wakabayashi J; Wakabayashi N; Yamamoto M; Kensler TW
    J Biol Chem; 2006 Sep; 281(36):26245-52. PubMed ID: 16857669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
    Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedles enhance topical delivery of 15-deoxy-Δ
    Macedo CG; Jain AK; Franz-Montan M; Napimoga MH; Clemente-Napimoga JT; Gill HS
    J Control Release; 2017 Nov; 265():22-29. PubMed ID: 28673836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
    Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
    Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages.
    Fu Y; Luo N; Lopes-Virella MF
    Atherosclerosis; 2002 Jan; 160(1):11-20. PubMed ID: 11755918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells.
    Jung WK; Lee CM; Lee DS; Na G; Lee DY; Choi I; Park SG; Seo SK; Yang JW; Choi JS; Lee YM; Park WS; Choi IW
    Int J Mol Med; 2014 Feb; 33(2):449-56. PubMed ID: 24337644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
    Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon H; Um JW; Sohn J; Song GG; Ji JD
    Exp Mol Med; 2005 Jun; 37(3):179-85. PubMed ID: 16000871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2).
    Kielian T; McMahon M; Bearden ED; Baldwin AC; Drew PD; Esen N
    J Neurochem; 2004 Sep; 90(5):1163-72. PubMed ID: 15312171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ
    Reddy AT; Lakshmi SP; Banno A; Reddy RC
    ACS Chem Biol; 2018 Dec; 13(12):3269-3278. PubMed ID: 30398845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of PPAR-γ agonist based on algal metabolites and the endogenous ligand 15-deoxy-Δ
    Ju Z; Su M; Hong J; Ullah S; La Kim E; Zhao CH; Moon HR; Kim S; Jung JH
    Eur J Med Chem; 2018 Sep; 157():1192-1201. PubMed ID: 30193217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
    Reyes-Martin P; Ramirez-Rubio S; Parra-Cid T; Bienes-Martínez R; Lucio-Cazana J
    Pharmacol Res; 2008 May; 57(5):344-50. PubMed ID: 18456507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.